{"about":{"non_affiliation":"Code with Papers and Syntology are not affiliated with, endorsed by, or sponsored by Papers with Code, Meta, or the pwc-archive mirror.","site":"https://codewithpapers.app","licence":"CC BY-SA 4.0","licence_url":"https://creativecommons.org/licenses/by-sa/4.0/legalcode","attribution":"https://codewithpapers.app/attribution","modified":"archive material modified by Syntology; see the attribution page","syntology":{"site":"https://syntology.ai","developers":"https://syntology.ai/developers","mcp":{"server":"https://syntology.ai/mcp","transport":"streamable-http","server_card":"https://syntology.ai/.well-known/mcp/server-card.json","auth":{"type":"trial token, no account","trial_token":"https://syntology.ai/api/oauth/trial/token","method":"POST","docs":"https://syntology.ai/developers"}},"have":"https://syntology.ai/api/graph/have?x=<method, arXiv id or title> (free, answers coverage only)","paper_base":"https://syntology.ai/paper/","atlas_base":"https://app.syntology.ai/?focus="},"machine_readable":[{"url":"https://codewithpapers.app/llms.txt","what":"the machine catalog: every machine-readable file, counted"},{"url":"https://codewithpapers.app/index/manifest.json","what":"paper-to-code index by arXiv id, with Syntology's counts"},{"url":"https://codewithpapers.app/search/manifest.json","what":"site search index (titles, authors) and its files"},{"url":"https://codewithpapers.app/download","what":"bulk files: Syntology's layer, described there"},{"url":"https://codewithpapers.app/build_manifest.json","what":"the build record: inputs, counts, exclusions, probes"}]},"url":"/paper/benchmarking-deep-graph-generative-models-for","title":"Benchmarking Deep Graph Generative Models for Optimizing New Drug Molecules for COVID-19","arxiv_id":"2102.04977","date":"2021-02-09","proceeding":null,"authors":["Logan Ward","Jenna A. Bilbrey","Sutanay Choudhury","Neeraj Kumar","Ganesh Sivaraman"],"abstract":"Design of new drug compounds with target properties is a key area of research in generative modeling. We present a small drug molecule design pipeline based on graph-generative models and a comparison study of two state-of-the-art graph generative models for designing COVID-19 targeted drug candidates: 1) a variational autoencoder-based approach (VAE) that uses prior knowledge of molecules that have been shown to be effective for earlier coronavirus treatments and 2) a deep Q-learning method (DQN) that generates optimized molecules without any proximity constraints. We evaluate the novelty of the automated molecule generation approaches by validating the candidate molecules with drug-protein binding affinity models. The VAE method produced two novel molecules with similar structures to the antiretroviral protease inhibitor Indinavir that show potential binding affinity for the SARS-CoV-2 protein target 3-chymotrypsin-like protease (3CL-protease).","url_abs":"https://arxiv.org/abs/2102.04977v1","url_pdf":"https://arxiv.org/pdf/2102.04977v1.pdf","source":{"archive":"pwc-archive (Hugging Face), CC BY-SA 4.0","snapshot":"2025-07-28","licence_url":"https://creativecommons.org/licenses/by-sa/4.0/legalcode","row_kind":"abstracts"},"code_links":[{"paper_slug":"benchmarking-deep-graph-generative-models-for","repo_url":"https://github.com/exalearn/covid-drug-design","is_official":1,"mentioned_in_paper":1,"mentioned_in_github":0,"framework":"pytorch","reach":null}],"tasks":[{"task_slug":"benchmarking","task_name":"Benchmarking"},{"task_slug":"q-learning","task_name":"Q-Learning"}],"methods":[{"method_slug":"q-learning","method_name":"Q-Learning"}],"datasets_introduced":[],"methods_introduced":[],"results":[],"syntology":{"syntology_url":"https://syntology.ai/paper/2102.04977","atlas_url":"https://app.syntology.ai/?focus=2102.04977","mcp":null,"developers":"https://syntology.ai/developers","held":true,"reason":"arxiv_id_in_atlas","checked_against":{"atlas_ids":549449,"atlas_ids_sha256":"afd72399dafd9906e9062927f70655952385a3d75488558e1f0484e950ab09b7","read_at":"2026-10-05T01:46:21Z"},"agent_calls":[{"tool":"get_citation_path","arguments":{"paper_1":"2102.04977"},"arguments_in":{"paper_2":"another paper's arXiv id or title"},"call":"get_citation_path(paper_1=\"2102.04977\", paper_2=\"…\")"},{"tool":"get_concepts_for_paper","arguments":{"arxiv_id":"2102.04977"},"call":"get_concepts_for_paper(arxiv_id=\"2102.04977\")"}],"by_repo":[{"repo":"exalearn/covid-drug-design","kind":"official","samples":0,"ran":0,"instrument":0,"unverified":0}],"by_repo_is":"one row per repository in the archive's code links, Syntology's graph links or the samples; samples 0 means no sample is linked to this paper, a statement about Syntology's coverage, not about the repository: with harvested_for_other_papers present, Syntology harvested the repository for that many other papers, and without it, Syntology harvested nothing from it; placed_by_identical_code counts samples whose link records no repository, placed here because identical code was harvested from this repository for another paper; ran counts executions on a synthesized input and instrument counts failures of Syntology's instrument, not of the code"},"code_links_note":null,"arxiv_metadata":null,"syntology_extracted_results":null,"record_sha256":"76d7122dacce02e4e15ed051bc534efb098fff991917fe6a84c96f5eae15c586","record_changed_at":"2026-09-28","record_changed_at_basis":"first_hashed"}